Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (251-260 of 304) with videos related to

Pageof 31
Sort By:
Diabetes Care|April 23, 2013
Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic studySonia S Anand, David Meyre, Guillaume Pare, et al.
The New England Journal of Medicine|July 21, 2017
ANGPTL3 Inhibition in Homozygous Familial HypercholesterolemiaDaniel Gaudet, Daniel A Gipe, Robert Pordy, et al.
JAMA Cardiology|February 12, 2025
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE TrialRobert S Rosenson, J Antonio G López, Daniel Gaudet, et al.
Human Genetics|May 29, 2007
A locus on chromosome 10 influences C-reactive protein levels in two independent populationsUlrich Broeckel, Christian Hengstenberg, Bjoern Mayer, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Circulation|July 19, 2017
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial HypercholesterolemiaDirk J Blom, Maurizio R Averna, Emma A Meagher, et al.
Environmental Health Perspectives|October 18, 2014
Prenatal exposure to maternal cigarette smoking and DNA methylation: epigenome-wide association in a discovery sample of adolescents and replication in an independent cohort at birth through 17 years of ageKen W K Lee, Rebecca Richmond, Pingzhao Hu, et al.
The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
The New England Journal of Medicine|November 7, 2022
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular DiseaseMichelle L O'Donoghue, Robert S Rosenson, Baris Gencer, et al.
Atherosclerosis|November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaborationG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Pageof 31

Showing results (251-260 of 304) with videos related to

Sort By:
Pageof 31
Diabetes Care|April 23, 2013
Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic studySonia S Anand, David Meyre, Guillaume Pare, et al.
The New England Journal of Medicine|July 21, 2017
ANGPTL3 Inhibition in Homozygous Familial HypercholesterolemiaDaniel Gaudet, Daniel A Gipe, Robert Pordy, et al.
JAMA Cardiology|February 12, 2025
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE TrialRobert S Rosenson, J Antonio G López, Daniel Gaudet, et al.
Human Genetics|May 29, 2007
A locus on chromosome 10 influences C-reactive protein levels in two independent populationsUlrich Broeckel, Christian Hengstenberg, Bjoern Mayer, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Circulation|July 19, 2017
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial HypercholesterolemiaDirk J Blom, Maurizio R Averna, Emma A Meagher, et al.
Environmental Health Perspectives|October 18, 2014
Prenatal exposure to maternal cigarette smoking and DNA methylation: epigenome-wide association in a discovery sample of adolescents and replication in an independent cohort at birth through 17 years of ageKen W K Lee, Rebecca Richmond, Pingzhao Hu, et al.
The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
The New England Journal of Medicine|November 7, 2022
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular DiseaseMichelle L O'Donoghue, Robert S Rosenson, Baris Gencer, et al.
Atherosclerosis|November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaborationG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Pageof 31